Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer

Joseph A. Sparano*, James Speyer, William J. Gradishar, Leonard Liebes, Rajeshwari Sridhara, Sandra Mendoza, David Fry, Merrill J. Egorin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences